These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3624835)

  • 21. Purulent corporeal cavernositis secondary to papaverine-induced priapism.
    Schwarzer JU; Hofmann R
    J Urol; 1991 Sep; 146(3):845-6. PubMed ID: 1875509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-traumatic priapism treated with metaraminol bitartrate: case report.
    Koga S; Shiraishi K; Saito Y
    J Trauma; 1990 Dec; 30(12):1591-3. PubMed ID: 2258979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epilepsy and hypertensive crisis after intracavernous injection of metaraminol in the treatment of priapism secondary to a papaverine test].
    Vailly B; Rougeron G; Weill A; Bollack C
    Presse Med; 1989 May; 18(20):1034-5. PubMed ID: 2524805
    [No Abstract]   [Full Text] [Related]  

  • 24. Nocturnal computed rigidity and tumescence evaluation in the prevention of the iatrogenic priapism.
    Quadraccia A; Salvini A; Cordani C; Pizzi P; Bellinzoni G
    Acta Urol Belg; 1988; 56(2):226-31. PubMed ID: 3400529
    [No Abstract]   [Full Text] [Related]  

  • 25. New treatment for priapism.
    Brindley GS
    Lancet; 1984 Jul; 2(8396):220-1. PubMed ID: 6146770
    [No Abstract]   [Full Text] [Related]  

  • 26. Priapism--a medical emergency.
    Nadig PW
    Tex Med; 1987 Sep; 83(9 Pt 1):6. PubMed ID: 3672394
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological priapism: comparison of trazodone- and papaverine-associated cases.
    Bardin ED; Krieger JN
    Int Urol Nephrol; 1990; 22(2):147-52. PubMed ID: 2354895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterotopic bone formation in the corpus cavernosum: a complication of papaverine-induced priapism.
    Vapnek J; Lue TF
    J Urol; 1989 Nov; 142(5):1323-4. PubMed ID: 2509734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of priapism lasting 24 hours or longer caused by intracavernosal injection of vasoactive drugs.
    Kulmala RV; Tamella TL
    Int J Impot Res; 1995 Jun; 7(2):131-6. PubMed ID: 7496442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local fibrinolysis and perfusion in the treatment of priapism of the corpora cavernosa and corpus spongiosum.
    Janetschek G; Promegger R; Weimann S
    Scand J Urol Nephrol; 1993; 27(4):545-7. PubMed ID: 8159931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Papaverine-induced priapism: 2 case reports.
    Halsted DS; Weigel JW; Noble MJ; Mebust WK
    J Urol; 1986 Jul; 136(1):109-10. PubMed ID: 3712593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy.
    McMahon CG
    Int J Impot Res; 2003 Oct; 15(5):383-4. PubMed ID: 14562142
    [No Abstract]   [Full Text] [Related]  

  • 33. [Metaraminol in therapy of various forms of priapism].
    Block T; Sturm W; Ernst G; Staehler G; Schmiedt E
    Urologe A; 1988 Jul; 27(4):225-9. PubMed ID: 3140463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prazosin-induced priapism.
    Baños JE; Bosch F
    Br J Urol; 1989 Aug; 64(2):205-6. PubMed ID: 2597255
    [No Abstract]   [Full Text] [Related]  

  • 35. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
    Wyndaele JJ; de Meyer JM; de Sy WA; Claessens H
    Paraplegia; 1986 Oct; 24(5):271-5. PubMed ID: 3774363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence.
    Levine SB; Althof SE; Turner LA; Risen CB; Bodner DR; Kursh ED; Resnick MI
    J Urol; 1989 Jan; 141(1):54-7. PubMed ID: 2908954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Papaverine-induced priapism: case report.
    Liu LH; Liu LC; Huang CH; Chiang CP
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Oct; 3(10):682-3. PubMed ID: 3482263
    [No Abstract]   [Full Text] [Related]  

  • 38. [Methylene blue: an effective therapeutic alternative for priapism induced by intracavernous injection of vasoactive agents].
    Martínez Portillo FJ; Fernández Arancibia MI; Bach S; Alken P; Jünemann KP
    Arch Esp Urol; 2002 Apr; 55(3):303-8. PubMed ID: 12068762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How safe is the treatment of impotence with intracavernous autoinjection?
    Zentgraf M; Ludwig G; Ziegler M
    Eur Urol; 1989; 16(3):165-71. PubMed ID: 2663519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiology of erection and pharmacological management of impotence.
    Lue TF; Tanagho EA
    J Urol; 1987 May; 137(5):829-36. PubMed ID: 3553617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.